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Biliary complications remain a significant problem following liver transplantation in the Model for End-Stage Liver Disease
(MELD) era. We hypothesized that donor, recipient, and technical variables may differentially affect anastomotic biliary
complications in MELD era liver transplants. We reviewed 256 deceased donor liver transplants after the institution of MELD
at our center and evaluated these variables’ association with anastomotic biliary complications. The bile leak rate was 18%,
and the stricture rate was 23%. Univariate analysis revealed that recipient age, MELD, donor age, and warm ischemia were
risk factors for leak, whereas a Roux limb or stent was protective. A bile leak was a risk factor for anastomotic stricture, whereas
use of histidine tryptophan ketoglutarate (HTK) versus University of Wisconsin (UW) solution was protective. Additionally, use
of a transcystic tube/stent was also protective. Multivariate analysis showed that warm ischemia was the only independent risk
factor for a leak, whereas development of a leak was the only independent risk factor for a stricture. HTK versus UW use and
transcystic tube/stent use were the only independent protective factors against stricture. Use of an internal stent trended in the
multivariate analysis toward being protective against leaks and strictures, but this was not quite statistically significant. This
represents one of the first MELD era studies of deceased donor liver transplants evaluating factors affecting the incidence of
anastomotic bile leaks and strictures. Donor, recipient, and technical factors appear to differentially affect the incidence of
anastomotic biliary complications, with warm ischemia, use of HTK, and use of a stent emerging as the most important
variables. Liver Transpl 14:73-80, 2008. © 2007 AASLD.
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Although the indications and overall success rate for
liver transplantation have increased steadily over the
past couple of decades, biliary complications continue
to add morbidity to this procedure. The majority of
these complications are related to the biliary anastomo-
sis, with the earliest series noting biliary complication
rates of 10%-30%.1-5 Despite advances in surgical tech-
nique, biliary complication rates remain high in con-
temporary series.6 A variety of interventions are avail-
able to treat and diagnose biliary complications, but
these complications still represent a large source of
morbidity and financial burden to liver transplant pa-
tients.7
Multiple risk factors for biliary complications have
been identified. Use of living donor livers is associated
with a higher risk of biliary complications.6,8 Placement
of a T-tube has also been identified as a culprit in the
development of these complications.9 Clearly, bile leaks
are thought to promote development of biliary stric-
tures,1,6 and hepatic arterial complications promote
both bile leaks and strictures.1,10,11 Debate has cen-
tered on the type of biliary reconstruction,1,12,13 use of
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stents,12,14 and recipient factors of illness severity,
such as preoperative serum bilirubin and international
normalized ratio.6 However, the relative influence of
these factors and their interactions with other variables
on the risk of biliary complications is not completely
known in contemporary liver transplant experience.
Since February 27, 2002, the Model for End-Stage
Liver Disease (MELD) allocation system has shifted liver
transplant allocation priority toward sicker patients,15
while at the same time donor criteria have expanded in
an attempt to keep up with the growing list of liver
transplant candidates. In addition, overall indications
for transplantation and immunosuppressive regimens
have changed over time. MELD scores and MELD com-
ponents clearly affect survival and complication rates,
specifically in certain patient populations.16,17 The
overall impact of these changes in liver transplantation
policy on the incidence of biliary complications among
decease donor liver transplants has not been described.
In addition, a contemporary detailed analysis of donor,
recipient, and technical issues that may contribute to
or be protective against these morbid complications has
yet to be performed for the MELD era. We therefore
examined the influence of these variables on the inci-
dence of anastomotic biliary complications during the
MELD era and hypothesized that they differentially im-
pact the development of anastomotic bile leaks and
strictures. To test this hypothesis, we retrospectively
assessed the association of donor, recipient, and tech-
nical variables with biliary anastomotic complications
in 256 consecutive deceased donor liver transplants




A total of 256 consecutive deceased donor liver trans-
plants among 238 patients were reviewed at the Uni-
versity of Michigan Medical Center between July 1,
2002 and June 30, 2005. Patients were identified by an
administrative database, and all data were retrieved
from patient records where appropriate. Procurement
records were obtained from the Michigan Organ Pro-
curement Organization (Gift of Life Michigan). All pa-
tients had at least 6 months of follow-up. To capture the
effects of as many potential variables as possible on
biliary complications, all transplants were evaluated
regardless of age, etiology of liver failure/transplant
indication, or method of biliary reconstruction. All data
for the current study were collected in accordance with
the University of Michigan Institutional Review Board.
Endoscopic retrograde cholangiopancreatogram, per-
cutaneous transhepatic cholangiogram, or transcystic
tube injections were performed for clinical suspicion of
a bile leak or stricture where appropriate. A transcystic
tube was placed selectively in some patients undergo-
ing a choledochocholedochostomy at the discretion of
the surgeon’s practice preference. Briefly, this tube
served as a combined external and internal stent that
traversed the duct-to-duct anastomosis and exited via
the cystic duct and gallbladder fossa. A minimum of 1
cholangiogram was performed usually within the first
10 postoperative days in patients receiving a transcys-
tic tube, which was discontinued at 6 weeks postoper-
atively. Additional cholangiograms were performed via
the transcystic tube as clinically indicated. An internal
stent alone was also used in selected cases, again at the
discretion of the surgeon. A Roux-en-Y hepaticojeju-
nostomy was used at the discretion of the surgeon,
usually in patients with primary sclerosing cholangitis
(PSC) or biliary atresia. Otherwise, patients underwent
an end-to-end choledochocholedochostomy. Anasto-
moses were created with absorbable sutures in an in-
terrupted fashion. Patients were classified as having an
anastomotic bile leak if they had evidence of a leak from
endoscopic retrograde cholangiopancreatogram, percu-
taneous transhepatic cholangiogram, or transcystic
tube cholangiograms. In a few patients, a bile leak was
diagnosed upon re-exploration for either suspected
thrombosis or bowel perforation. An anastomotic bili-
ary stricture was defined as any obstructive lesion at
the anastomosis detected postoperatively by cholan-
giography that required a therapeutic intervention,
such as stent placement, cholangioplasty, or stent ex-
change. A stricture was not defined as a size mismatch.
Intrahepatic (nonanastomotic) strictures were not in-
cluded in this analysis.
The immunosuppression regimen usually consisted
of triple therapy and included either cyclosporine or
tacrolimus with prednisone and mycophenolate
mofetil. A separate analysis of 50 patients who were
part of a steroid avoidance protocol showed no effect of
this protocol on the incidence of biliary complications,
and these recipients were included in the present anal-
ysis.18 Immunosuppression was decreased or mini-
mized as appropriate in the presence of significant in-
fections or adverse side effects.
University of Wisconsin (UW) solution was used as a
preservative during organ procurement during the first
half of the study period. Subsequently, a decision was
made by the local organ procurement organization to
use histidine tryptophan ketoglutarate (HTK) preserva-
tion solution for the remainder of the period. All donors
were deceased; no donation after cardiac death donors
were included in the analysis. Donor procurement was
performed via a retrograde aortic flush with a suprace-
liac aortic cross clamp. Blood and perfusate were
vented through the cavoatrial junction or the infrarenal
inferior vena cava. Approximately 4-5 L of either HTK or
UW solution was used, and this was followed by pack-
ing in the same solution. The gallbladder and bile duct
were flushed on the back table. A portal venous flush of
250-350 mL was routinely performed on the back table.
Statistical Analysis
Categorical variables were expressed as a percentage,
and continuous variables were expressed as a mean 
standard deviation. A chi-square or unpaired t test was
used where appropriate. Univariate logistic regression
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analysis was performed on the following variables: do-
nor age, donor gender, donor creatinine, recipient age,
recipient gender, recipient match MELD, recipient di-
agnosis/indication, warm ischemia time, cold ischemia
time, total ischemia time, use of HTK versus UW pres-
ervation solution, use of an internal stent, use of a
transcystic tube, and use of a Roux-en-Y choledochoje-
junostomy. A multivariate logistic regression analysis
was performed on variables found to be statistically
significant in the univariate analysis or with P  0.20
and on variables that had other potential biologic or
clinical relevance.
All statistical analyses were performed with SAS soft-
ware (Statview 5.0.1, SAS Institute, Inc., Cary, NC).
Variables in all analyses with a P value of less than 0.05
were considered significant.
RESULTS
Demographics and Clinical Outcomes
The baseline recipient, donor, and technical character-
istics of the 256 transplants for the MELD era (7/02-
6/05) are listed in Table 1. The mean age of recipients
was 43 years, with a majority being male (63%). A ma-
jority of these recipients were classified as adults (83%,
age 17 or greater). Of the children, 31 were small (age 
12), with 12 being adolescent (age  12). The mean
MELD/Pediatric End-Stage Liver Disease score was
22.8  6. Hepatitis C was the most common indication
for transplantation, making up 37% of the recipients.
Biliary atresia was the most common indication for
small children (n  15 or 48%). PSC was the most
common cholestatic indication for transplantation,
making up 6.6% of the recipients.
The mean donor age, as expected, was lower than the
recipient age and was 34 years. A majority of donors
were male, comprising 60%. The proportions of donors
for whom HTK and UW solutions were used were 55%
and 45%, respectively. A choledochocholedochostomy
was performed in most cases, with 23% undergoing a
Roux-en-Y hepaticojejunostomy. An internal stent was
used in 14% of transplants, whereas a transcystic
tube/stent (internal/external) was used in 16%. A Roux
limb was used in all children with biliary atresia,
whereas 9 of 16 small children without biliary atresia
underwent Roux limb reconstruction.
Following liver transplantation, there were 41
deaths (16%), 3 hepatic artery thromboses, and 3
cases of primary nonfunction (Table 2). A cholangio-
gram was performed for clinical indications or for
surveillance of a transcystic tube in 53% of trans-
plants. Essentially, all those with a transcystic tube
were studied, whereas 44% of those without a tube
underwent a cholangiogram on the basis of clinical
indications. An anastomotic bile leak or anastomotic
stricture was diagnosed in 18% and 23% of trans-
plants, respectively. For pediatric patients, there
were a total of 2 anastomotic bile leaks, 1 in an infant
with biliary atresia and 1 in an adolescent with ful-
minant hepatic failure. Of those that had a leak,
44.7% subsequently developed an anastomotic stric-
ture, which comprised 8.2% of the total transplants.
The incidence of death did not appear to be associ-
ated with the development of a bile leak [odds ratio
(OR) 0.78, confidence interval (CI) 0.31-1.99, P 
0.603] or a stricture (OR 0.70, CI 0.29-1.68, P 
0.421).
TABLE 1. Demographic Information
Recipient characteristics, n (%)
Age (years), mean (SD) 43 (19)
Female 89 (37)
Male 153 (63)
Pediatric (age  17) 43 (17)
Adult 213 (83)
MELD, mean (SD) 22.8 (6)
Etiology or indication, n (%)
Hepatitis C 95 (37)






Biliary atresia 16 (6.3)
Hepatitis B 8 (3.1)
Autoimmune 10 (6.3)
Other 4 (1.6)
Donor characteristics, n (%)
Age (years), mean (SD) 34 (8)
Female 83 (40)
Male 123 (60)
Pediatric (age  17) 40 (19)
Adult 166 (81)
Preservation, n (%)
HTK solution 141 (55)
UW solution 115 (45)
Biliary reconstruction, n (%)
Roux limb 58 (23)
Internal stent 37 (14)
Transcystic tube 42 (16)
No stent/tube/Roux 119 (46)
Abbreviations: HAT, hepatic artery thrombosis; HTK,
histidine tryptophan ketoglutarate; MELD, Model for End-
Stage Liver Disease; PBC, primary biliary cirrhosis; PNF,
primary nonfunction; PSC, primary sclerosing cholangitis;
SD, standard deviation; UW, University of Wisconsin.





Anastomotic bile leak 47 (18)
Anastomotic stricture 59 (23)
Leak and subsequent stricture 21 (8.2)
Abbreviations: HAT, hepatic artery thrombosis; PNF,
primary nonfunction.
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Predictors of Anastomotic Bile Leak
The distribution of bile leaks among donor, recipient,
and technical variables is listed in Tables 3 and 4. The
mean recipient age was higher for those who experi-
enced a bile leak (50.4 versus 40.8 years, P  0.003)
than for those without a leak. In addition, the mean
MELD score was significantly higher in those that
leaked (24.6 versus 22.3, P  0.021). Recipient gender
and disease etiology were not significantly associated
with a bile leak, although the sample size for some of
these disease categories was small. There were no pa-
tients with primary nonfunction or hepatic artery
thrombosis that experienced a bile leak, only 1 of 10
patients with autoimmune hepatitis had a leak, and
only 1 of 16 patients with biliary atresia had a leak.
Donor age was also significantly higher in cases that
had a bile leak (41.8 versus 32.0, P  0.003). Donor
gender, creatinine, and preservation solution were not
associated with an increased risk of bile leak. Warm
ischemia time was significantly prolonged in cases with
a bile leak (49.1 versus 41.9 minutes, P  0.024),
whereas cold and total ischemia times were not signif-
icantly different. The use of a Roux limb or an internal
stent reduced the leak rate to 6.9% (P  0.011) and
5.4% (P  0.029) of cases, respectively. A transcystic
tube did not appear to reduce the incidence of a bile
leak, with an incidence of 21.4%.
Univariate analysis of these risk factors using logistic
regression (Table 5) showed that recipient age, donor
age, MELD score, and warm ischemia time were all
positive predictors for the development of an anasto-
motic bile leak. However, use of a Roux limb or an
internal stent was protective against the development of
a bile leak, with ORs of 0.27 (CI 0.09-0.78) and 0.22 (CI
0.05-0.96), respectively. Variables found to be signifi-
cant in the univariate analysis or with a P value of less
than 0.20 or having additional clinical importance were
analyzed in a multivariate fashion (Table 6). Warm isch-
emia time appeared to be the only variable indepen-
dently associated with the development of a bile leak
(P  0.044). There was a trend for an increased risk of a
bile leak with increasing MELD in the multivariate
analysis, but this did not meet statistical significance
(P  0.085). Use of a Roux limb or an internal stent was
not independently protective in the multivariate analy-
sis (P  0.149 and P  0.072, respectively).
Predictors of Anastomotic Biliary Stricture
The same variables evaluated for the distribution of bile
leaks were analyzed for the distribution of anastomotic
strictures (Tables 4 and 7). In contrast to bile leaks, the
mean recipient age and mean MELD score did not differ
significantly between cases in which a stricture oc-
TABLE 3. Risk Factor Analysis for Anastomotic Bile Leak
No Leak Bile Leak P Value
Recipient age (years), mean (SD) 40.8 (11) 50.4 (20) 0.003
Recipient gender (male versus female, %) 62.8 65.1 0.081
MELD, mean (SD) 22.3 (6) 24.6 (7) 0.021
Donor age (years), mean (SD) 32.0 (18) 41.8 (16) 0.003
Donor gender (male versus female, %) 59.2 57.5 0.663
Donor Cr, mean (SD) 1.0 (0.8) 1.2 (1.5) 0.365
Preservation (HTK versus UW, %) 56.5 48.9 0.349
Warm ischemia (minutes), mean (SD) 41.9 (16) 49.1 (23) 0.024
Cold ischemia (minutes), mean (SD) 522 (154) 488 (98) 0.182
Total ischemia (minutes), mean (SD) 564 (154) 537 (100) 0.298
Abbreviations: Cr, creatinine; HTK, histidine tryptophan ketoglutarate; MELD, Model for End-Stage Liver Disease; SD,
standard deviation; UW, University of Wisconsin.
TABLE 4. Incidence of Leak or Stricture by Etiology/







Hepatitis C 21.3 0.380 26.3 0.327
Alcohol or cryptogenic 21.0 0.531 21.0 0.669
PSC 22.2 0.563 29.4 0.513
Fulminant 28.6 0.306 14.3 0.428
Retransplant 10.5 0.230 26.7 0.725
PNF/HAT 0.0 0.241 0.0 0.176
PBC 30.0 0.328 10.0 0.320
Biliary atresia 6.3 0.198 0.0 0.024
Autoimmune 10.0 0.489 60.0 0.005
Roux limb
Yes 6.9 0.011 20.7 0.641
No 21.6 23.6
Internal stent
Yes 5.4 0.029 10.8 0.058
No 20.5 25.0
Transcystic tube
Yes 21.4 0.574 11.8 0.034
No 17.8 25.7
Bile leak
Yes — — 44.7 0.001
No — 12.8
Abbreviations: HAT, hepatic artery thrombosis; PBC,
primary biliary cirrhosis; PNF, primary nonfunction; PSC,
primary sclerosing cholangitis.
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curred or did not. However, the mean donor age was
significantly increased (38.2 versus 32.5, P  0.046) for
those with an anastomotic stricture. The incidence of a
stricture was not significantly elevated among male re-
cipients versus female recipients or for any particular
disease etiology, with the exception of autoimmune
hepatitis, which had a 60% incidence (P  0.005). How-
ever, the incidence was significantly lower for patients
with biliary atresia, with zero patients being affected
(P  0.024). However, there was a very small sample
size for these 2 diagnoses. Use of HTK instead of UW
preservation solution was associated with a lower inci-
dence of anastomotic stricture, with 17.0% for HTK and
30.2% for UW (P  0.023). Use of an internal stent was
not quite significant with respect to the incidence of a
stricture (10.8%, P  0.058). Use of a Roux limb carried
an incidence of 20.7% for a stricture and was not sig-
nificantly different (P  0.641). However, a transcystic
tube was significantly associated with a lower rate of
stricture at 11.8% (P  0.034). Mean ischemia times
and donor creatinine did not differ among cases with or
without a stricture. Not surprisingly, development of a
bile leak was associated with a 44.7% incidence of a
subsequent stricture (P  0.001).
The univariate analysis using logistic regression of
variables that may be associated with the development
of a stricture is presented in Table 5. Use of HTK ap-
peared to be protective against a stricture (OR 0.48, CI
0.26-0.86, P  0.014), whereas use of an internal stent
trended toward being protective but was not quite sta-
tistically significant (OR 0.36, CI 0.12-1.07, P  0.067).
A transcystic tube was protective (OR 0.39, CI 0.16-
0.95, P  0.039). Donor age did not quite meet signifi-
cance as a risk factor for stricture (OR 1.02, CI 1.00-
1.04, P  0.054). The development of a bile leak
appeared to carry the highest relative risk among nom-
inal variables for the development of an anastomotic
stricture (OR 3.78, CI 1.92-7.45, P  0.0001). A multi-
TABLE 5. Univariate Analysis of Variables for Biliary Complications
Bile Leak Stricture
OR (CI) P Value OR (CI) P Value
Recipient age 1.03 (1.01–1.06) 0.005 1.01 (1.00–1.03) 0.151
Recipient gender (male versus female) 1.05 (0.53–2.09) 0.890 1.58 (0.83–3.03) 0.166
MELD 1.06 (1.01–1.12) 0.023 0.99 (0.94–1.04) 0.712
Etiology/indication
Hepatitis C 0.75 (0.39–1.43) 0.381 0.74 (0.41–1.35) 0.328
Alcohol or cryptogenic 0.80 (0.39–1.63) 0.532 1.16 (0.58–2.33) 0.669
PSC 1.41 (0.44–4.53) 0.565 1.44 (0.48–4.25) 0.515
Fulminant 0.54 (0.16–1.79) 0.313 1.84 (0.40–8.46) 0.434
Retransplant 0.30 (0.04–2.37) 0.256 1.24 (0.38–4.04) 0.725
Donor age 1.03 (1.01–1.05) 0.003 1.02 (1.00–1.04) 0.054
Donor gender (male versus female) 1.00 (0.50–2.00) 0.994 1.15 (0.61–2.14) 0.669
Donor Cr 1.15 (0.84–1.57) 0.378 1.06 (0.78–1.44) 0.728
Preservation (HTK versus UW) 0.74 (0.39–1.39) 0.350 0.48 (0.26–0.86) 0.014
Warm ischemia 1.02 (1.01–1.04) 0.030 1.00 (0.98–1.02) 0.911
Cold ischemia 1.00 (0.99–1.00) 0.183 1.00 (0.99–1.00) 0.999
Total ischemia 1.00 (0.99–1.00) 0.298 1.00 (0.99–1.00) 0.998
Roux limb 0.27 (0.09–0.78) 0.016 0.84 (0.41–1.72) 0.641
Internal stent 0.22 (0.05–0.96) 0.044 0.36 (0.12–1.07) 0.067
Transcystic tube 1.11 (0.51–2.42) 0.785 0.39 (0.16–0.95) 0.039
Bile leak NA NA 3.78 (1.92–7.45) 0.0001
Abbreviations: CI, confidence interval; Cr, creatinine; HTK, histidine tryptophan ketoglutarate; MELD, Model for End-Stage
Liver Disease; NA, not applicable; OR, odds ratio; PSC, primary sclerosing cholangitis; UW, University of Wisconsin.
TABLE 6. Multivariate Analysis of Variables for
Biliary Complications
OR (CI) P Value
Bile leak
Recipient age 1.02 (0.99–1.05) 0.179
MELD 1.06 (0.99–1.13) 0.085
Donor age 1.02 (1.00–1.04) 0.108
Warm ischemia 1.02 (1.00–1.04) 0.044
Cold ischemia 1.00 (0.99–1.00) 0.495
Roux limb 0.44 (0.15–1.34) 0.149
Internal stent 0.15 (0.02–1.18) 0.072
Stricture
Recipient age 1.01 (0.98–1.03) 0.765




Roux limb 1.20 (0.55–2.62) 0.655
Internal stent 0.37 (0.12–1.16) 0.088
Transcystic tube 0.30 (0.11–0.79) 0.015
Bile leak 3.63 (1.77–7.46) 0.001
Abbreviations: CI, confidence interval; HTK, histidine
tryptophan ketoglutarate; MELD, Model for End-Stage
Liver Disease; OR, odds ratio; UW, University of Wisconsin.
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variate analysis was subsequently performed (Table 6)
and showed that use of HTK and use of a transcystic
tube were independently protective against the devel-
opment of a stricture (OR 0.40, CI 0.21-0.75, P  0.005
and OR 0.30, CI 0.11-0.79, P  0.015, respectively).
Development of a bile leak appeared to be the only
independent negative risk factor for the development of
a stricture (P  0.001). Donor age, recipient age, use of
a Roux limb, and use of an internal stent were not
independent risk factors for development of a stricture.
However, when a bile leak was excluded from the mul-
tivariate analysis, use of an internal stent emerged as
being protective (OR 0.32, CI 0.10-0.98, P  0.046),
whereas the other covariates continued to be indepen-
dent risk factors.
DISCUSSION
Our study on MELD era liver transplants identifies sev-
eral risk factors for biliary complications. We differen-
tiate factors that influence the development of anasto-
motic leaks from those associated with anastomotic
strictures and distinguish the influence of donor, recip-
ient, and technical factors on these separate biliary
complications. Recipient age, recipient MELD score, do-
nor age, and warm ischemia time increased the risk of
bile leak in the univariate analysis, and use of a Roux
limb or an internal stent decreased the risk of a bile leak
in the univariate analysis, with warm ischemia time
emerging as the only independent risk factor after mul-
tivariate analysis. MELD score and use of an internal
stent demonstrated trends that did not quite reach sta-
tistical significance in the multivariate analysis for bile
leaks. In contrast, donor age and the development of a
bile leak were the only variables that increased the risk
of anastomotic stricture in the univariate analysis. In
addition, use of a transcystic tube or HTK preservation
solution decreased the risk of an anastomotic stricture
in the univariate analysis. Multivariate analysis
showed that the development of a bile leak and use of
HTK or a transcystic tube were the only negative and
positive risk factors, respectively, that independently
affected the rate of anastomotic stricture. Use of an
internal stent trended toward being protective against a
stricture in both the univariate and multivariate anal-
yses but did not quite meet statistical significance.
The reported incidence of biliary complications in his-
torical pre-MELD series is 10%-30%.1-5 Although at-
tempts have been made to understand the risk factors
involved and to study techniques of biliary reconstruc-
tion,1 these complications have remained high. Fur-
thermore, expanded use of donor organs, institution of
MELD, changes in viral prophylaxis, changes in immu-
nosuppression, and changing procurement techniques
have all occurred over the last 3-5 years.15 The impact
of this changing landscape on the rate of anastomotic
biliary complications and identification of contempo-
rary risk factors was the purpose of the present study.
Although historical studies indicate that cytomegalovi-
rus infection,19 hepatic artery thrombosis or steno-
sis,10,20 and ABO incompatibility21 all increase the bil-
iary complication rate, these factors are relatively
minimized in contemporary series as viral prophylaxis
has improved and events such as ABO incompatibility
and hepatic artery thrombosis are infrequent events.15
Additionally, many of these studies evaluated intrahe-
patic biliary strictures rather than anastomotic compli-
cations.
Some progress has been made recently in under-
standing technical factors that may influence the de-
velopment of anastomotic biliary complications. Re-
cently, a randomized, controlled, multicenter trial9 has
demonstrated that the use of a T-tube is associated
with a higher rate of biliary complications (33.3% ver-
sus 15.5%) mainly secondary to a higher bile leak rate.
T-tubes were not used in the current study; instead, a
transcystic tube/stent was used in some patients (16%)
and was associated with a lower rate of stricture forma-
tion. It should be noted that variable practices and
variable indications for use of a transcystic tube/stent
may confound some of these findings in this retrospec-
tive study. Additionally, there may be some selection
bias with a transcystic tube as all of these underwent
cholangiography to screen for a possible leak. Although
living donor liver transplantation has been associated
TABLE 7. Risk Factor Analysis for Anastomotic Stricture
No Stricture Stricture P Value
Recipient age (years), mean (SD) 42.3 (21) 46.7 (15) 0.137
Recipient gender (male versus female, %) 61.8 71.9 0.164
MELD, mean (SD) 22.7 (6) 22.5 (6) 0.842
Donor age (years), mean (SD) 32.5 (18) 38.2 (17) 0.046
Donor gender (male versus female, %) 57.5 60.0 0.921
Donor Cr, mean (SD) 1.0 (1.0) 1.1 (0.8) 0.728
Preservation (HTK versus UW, %) 81.6 17.0 0.023
Warm ischemia (minutes), mean (SD) 43.3 (18) 43.1 (19) 0.922
Cold ischemia (minutes), mean (SD) 515 (140) 515 (161) 0.979
Total ischemia (minutes), mean (SD) 558 (140) 558 (160) 0.998
Abbreviations: Cr, creatinine; HTK, histidine tryptophan ketoglutarate; MELD, Model for End-Stage Liver Disease; SD,
standard deviation; UW, University of Wisconsin.
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with a higher biliary complication rate,6,8 some recent
analyses of technical variables have provided some in-
sight. A retrospective study by Kasahara et al.12 in
living donor liver transplantation has shown that duct-
to-duct or primary anastomoses were associated with a
lower bile leak rate of 4.7%, but a higher stricture rate
of 26.6%, when compared to Roux-en-Y reconstruction,
for which the rates were 12.4% and 8.3%, respectively.
The current findings differ somewhat from those of
studies on pre-MELD liver transplants. A previous
study showed that Roux-en-Y reconstruction did not
result in a different bile leak rate, whereas the stricture
rate was higher.1 The finding of a lower bile leak rate
with use of a Roux limb in the current study may be
attributable to differences in donor age, ischemia time,
and recipient illness severity as measured by MELD
between the 2 eras. Unfortunately, we do not have ac-
curately controlled pre-MELD data to examine this is-
sue. The fact that a Roux limb appeared to lower the
leak rate without a realizable difference in stricture rate
could mean that a Roux limb has an inherent predis-
position to stricture independent of a leak, similarly to
previous studies.1 Although warm ischemia time has
not been found to be a significant factor for develop-
ment of anastomotic biliary complications,6,12 warm
ischemia time was clearly an independent risk factor for
deceased donor transplants in the current study. Use of
a stent is clearly an unsettled issue as these same
studies have had some success in decreasing the rate of
stricture.12 This is somewhat in concordance with the
present study in that use of a stent was protective
against leaks in the univariate analysis and trended
toward being significant in the multivariate analysis for
being protective against both leaks and strictures.
When bile leaks were excluded from the multivariate
analysis for stricture, a stent was independently pro-
tective against a stricture. However, insufficient sample
size limits the ability to make firm recommendations
about stenting. The issue of selection bias in terms of
Roux reconstruction or stenting may certainly exist in
this retrospective study. Clearly, a prospective trial may
help to further establish the risks and benefits of biliary
stents.
MELD score was associated with a higher bile leak
rate in univariate analysis but did not quite meet sig-
nificance in the multivariate analysis. Another study6
had implicated certain MELD components (bilirubin
level and international normalized ratio) to be risk fac-
tors for biliary complications. However, MELD, when
analyzed as a single variable, was not found to be sig-
nificant. In this study, recipient age was not found to be
significant, whereas we found recipient age and donor
age to be significant risks for bile leaks in the univariate
analysis. Cold ischemia time has been implicated to
cause a higher biliary complication rate; however, most
of this effect has been primarily associated with intra-
hepatic strictures.22,23 We did not find an association of
cold ischemia time with anastomotic strictures.
Whether these differences in risk factors are related to
changing policy trends, because of the multifactorial
nature of these complications, is uncertain. Clearly,
some of these changing trends have had effects on over-
all patient and allograft survival.15
HTK is currently widely used as a preservation solu-
tion secondary to its lower cost and acceptable graft
survival outcomes.24 Smaller studies have also impli-
cated that use of HTK may result in a lower rate of
biliary complications than UW solution,25,26 which is
possibly related to lower viscosity. Our present study
supports this contention in that HTK was indepen-
dently protective against anastomotic biliary stricture.
Therefore, use of HTK may serve to limit the develop-
ment of anastomotic biliary stricture, although this was
not tested in a randomized fashion. Certainly, one can-
not exclude a potential era effect in this retrospective
study.
Our study certainly has limitations with respect to its
retrospective nature and limited sample size in certain
variables. As discussed earlier, sample size was limited
with respect to use of stents but also with respect to
some of the recipient diagnoses. We found no direct
influence of diagnosis or transplant indication on the
incidence of anastomotic biliary complications, al-
though those recipients with autoimmune hepatitis ap-
peared to have a higher rate of anastomotic stricture,
whereas those with biliary atresia appeared to have a
lower rate. Recent literature for PSC has failed to show
an increased rate of anastomotic stricture, whereas the
rates of intrahepatic strictures are clearly increased.27
However, use of Roux-en-Y reconstruction has been
determined to be superior in PSC patients with a de-
creased stricture rate.13 Likewise, autoimmune hepati-
tis recipients undergoing transplantation have been
shown to have higher rejection rates and intrahepatic
stricture rates, with no clear evidence at this time of
higher anastomotic complication rates.28
This contemporary study identifies several risk fac-
tors for anastomotic bile leaks and anastomotic stric-
tures among MELD era liver transplants. Recipient age,
donor age, MELD score, and warm ischemia time ap-
pear to have a greater impact on leak rates. Use of a
stent or a Roux limb appeared to be protective against
leaks, whereas other technical factors such as use of
HTK and use of a transcystic tube/stent appeared to be
protective against anastomotic strictures. Development
of a bile leak was the largest risk factor for the develop-
ment of an anastomotic stricture. The results of the
current study make an argument that donor, recipient,
and technical factors can differentially contribute to the
risk of anastomotic biliary complications. However,
warm ischemia time, HTK preservation solution, and
the use of an internal stent emerged as being most
important on the basis of the multivariate analysis.
Technical factors, such as the decision to use a stent or
Roux limb reconstruction, in the context of higher do-
nor and recipient risk combinations are certainly wor-
thy of additional prospective study. Although the
present study is retrospective, the routine use of HTK
does not appear to increase the risk of anastomotic
biliary complications and may serve to lower that risk
on the basis of the present data.
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